These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35921122)

  • 1. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
    ; Crystal JS; Thompson JF; Hyngstrom J; Caracò C; Zager JS; Jahkola T; Bowles TL; Pennacchioli E; Beitsch PD; Hoekstra HJ; Moncrieff M; Ingvar C; van Akkooi A; Sabel MS; Levine EA; Agnese D; Henderson M; Dummer R; Neves RI; Rossi CR; Kane JM; Trocha S; Wright F; Byrd DR; Matter M; Hsueh EC; MacKenzie-Ross A; Kelley M; Terheyden P; Huston TL; Wayne JD; Neuman H; Smithers BM; Ariyan CE; Desai D; Gershenwald JE; Schneebaum S; Gesierich A; Jacobs LK; Lewis JM; McMasters KM; O'Donoghue C; van der Westhuizen A; Sardi A; Barth R; Barone R; McKinnon JG; Slingluff CL; Farma JM; Schultz E; Scheri RP; Vidal-Sicart S; Molina M; Testori AAE; Foshag LJ; Van Kreuningen L; Wang HJ; Sim MS; Scolyer RA; Elashoff DE; Cochran AJ; Faries MB
    JAMA Surg; 2022 Sep; 157(9):835-842. PubMed ID: 35921122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter Adoption and Outcomes of Nodal Observation for Patients with Melanoma and Sentinel Lymph Node Metastases.
    Parvez E; Khosrow-Khavar F; Dumitra T; Nessim C; Bernard-Bédard É; Rivard J; Pravong V; Wang S; Gervais MK; Meterissian S; Dumitra S
    Ann Surg Oncol; 2023 Feb; 30(2):1195-1205. PubMed ID: 36282456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease.
    Uppal A; Stern S; Thompson JF; Foshag L; Mizzollo N; Nieweg OE; Hoekstra HJ; Roses DF; Sondak VK; Kashani-Sabet M; Coventry BJ; Cochran AJ; Fujita M; Sim-Shin M; Elashoff D; Elashoff RM; Faries MB
    Ann Surg Oncol; 2020 Jun; 27(6):1970-1977. PubMed ID: 31863416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
    Broman KK; Hughes TM; Dossett LA; Sun J; Carr MJ; Kirichenko DA; Sharma A; Bartlett EK; Nijhuis AA; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma J; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras RM; Teras J; Farrow NE; Beasley GM; Hui JY; Been L; Kruijff S; Boulware D; Sarnaik AA; Sondak VK; Zager JS;
    J Am Coll Surg; 2021 Apr; 232(4):424-431. PubMed ID: 33316427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
    Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.
    Morton DL; Cochran AJ; Thompson JF; Elashoff R; Essner R; Glass EC; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Wang HJ;
    Ann Surg; 2005 Sep; 242(3):302-11; discussion 311-3. PubMed ID: 16135917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
    Sinnamon AJ; Song Y; Sharon CE; Yang YX; Elder DE; Zhang PJ; Xu X; Roses RE; Kelz RR; Fraker DL; Karakousis GC
    Ann Surg Oncol; 2018 Nov; 25(12):3469-3475. PubMed ID: 30043316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
    Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
    Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous lymphatic drainage in patients with grossly involved nodal basins.
    Kamath D; Brobeil A; Stall A; Lyman G; Cruse CW; Glass F; Fenske N; Messina J; Berman C; Reintgen D
    Ann Surg Oncol; 1999 Jun; 6(4):345-9. PubMed ID: 10379854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?
    Rios-Cantu A; Lu Y; Melendez-Elizondo V; Chen M; Gutierrez-Range A; Fadaki N; Thummala S; West-Coffee C; Cleaver J; Kashani-Sabet M; Leong SPL
    Clin Exp Metastasis; 2017 Jun; 34(5):345-350. PubMed ID: 28699042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodal Basin Recurrence After Sentinel Lymph Node Biopsy for Melanoma: A Retrospective Multicenter Study in 2653 Patients.
    Kretschmer L; Bertsch HP; Zapf A; Mitteldorf C; Satzger I; Thoms KM; Völker B; Schön MP; Gutzmer R; Starz H
    Medicine (Baltimore); 2015 Sep; 94(36):e1433. PubMed ID: 26356697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases.
    Landi G; Polverelli M; Moscatelli G; Morelli R; Landi C; Fiscelli O; Erbazzi A
    J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):35-45. PubMed ID: 10877250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observation after a positive sentinel lymph node biopsy in patients with melanoma.
    Bamboat ZM; Konstantinidis IT; Kuk D; Ariyan CE; Brady MS; Coit DG
    Ann Surg Oncol; 2014 Sep; 21(9):3117-23. PubMed ID: 24833100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
    Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
    World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma.
    Gershenwald JE; Berman RS; Porter G; Mansfield PF; Lee JE; Ross MI
    Ann Surg Oncol; 2000 Apr; 7(3):226-31. PubMed ID: 10791854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Regional Lymph Node Recurrence in the Modern Age of Tumor-Positive Sentinel Node Melanoma: The Role of the First Postoperative Ultrasound.
    Keller J; Stern S; Chang SC; Marcus R; Weiss J; Nassoiy S; Christopher W; Fischer T; Essner R
    Ann Surg Oncol; 2022 Dec; 29(13):8469-8477. PubMed ID: 35989390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).
    Cochran AJ; Wen DR; Huang RR; Abrishami P; Smart C; Binder S; Scolyer RA; Thompson JF; Stern S; Van Kreuningen L; Elashoff DE; Sim MS; Wang HJ; Faries MB;
    Eur J Surg Oncol; 2022 Jun; 48(6):1280-1287. PubMed ID: 35246348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: Reliability of the procedure and analysis of failures after long-term follow-up.
    Jacobs IA; Chevinsky AH; Swayne LC; Magidson JG; Britto EJ; Smith TJ
    J Surg Oncol; 2001 Jul; 77(3):157-64. PubMed ID: 11455551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.